Brief: Unity Biotechnology Posts Qtrly Loss Per Share 18 Cents
15/03/2022 12:14
March 15 (Reuters) - UNITY Biotechnology Inc UBX.O :
* UNITY BIOTECHNOLOGY, INC. REPORTS FOURTH QUARTER AND FULL
YEAR
2021 FINANCIAL RESULTS AND BUSINESS UPDATES
* UNITY BIOTECHNOLOGY, INC. REPORTS Q4 AND FULL YEAR 2021
FINANCIAL RESULTS AND BUSINESS UPDATES
* BELIEVES CURRENT CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES ARE SUFFICIENT TO FUND OPERATIONS INTO Q1 OF 2023
* QTRLY LOSS PER SHARE $0.18
* Q4 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9qRmLJ
Further company coverage: UBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force